Billionaire Profile
R
Global Rank
#3332

Image: Apwebmaster | CC BY-SA 3.0 | via Wikimedia Commons

Rao Wei & family

CEO, Shenzhen New Industries Biomedical Engineering
CN
Real-Time Net Worth
$1B
Estimated based on Shenzhen New Industries Biomedical Engineering stock value as of April 20, 2026
Age
61
Source
Pharmaceuticals
Industry
healthcare
Citizenship
CN

Biography

Rao Wei, a 61-year-old Chinese entrepreneur, chairs Shenzhen New Industries Biomedical Engineering, a supplier of clinical laboratory instruments. He is listed on the Forbes 2026 Billionaires list. His journey began in 1997 when he joined the company as a trading firm. The company went public in 2020. Rao's source of wealth is pharmaceuticals, and he has a doctorate from Wuhan University of Technology. His career is a testament to his dedication and vision in the healthcare industry, building a business that provides innovative medical solutions and contributing to China's life sciences sector. He also has a foundation in Wilmington, DE which has a revenue of $1.3 million in 2024.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Rao Wei's early life details are not widely available in the public domain. However, it's known that he holds a doctorate from Wuhan University of Technology.

Rise to Success

Rao Wei's career took a significant turn in 1997 when he joined Shenzhen New Industries Biomedical Engineering, a company that was then a trading company with just a dozen employees. Through his leadership, the company grew and evolved. The company went public on the Shenzhen Stock Exchange in 2020, raising $192 million, with funds earmarked for R&D and manufacturing. This event was a major milestone, solidifying his position and expanding the company's capabilities in the healthcare sector.

Key Business Strategies

Rao Wei chairs Shenzhen New Industries Biomedical Engineering, a supplier of clinical laboratory instruments. The company's focus on R&D and manufacturing highlights a strategy centered around innovation and growth. The decision to go public in 2020 demonstrates a strategic move to access capital for further development and expansion within the pharmaceutical and healthcare industry.

Philanthropy

There is not much information about Rao Wei's philanthropy. A foundation, Rao Family Foundation, was started in 2021.

Career Milestones

1997

Joined Shenzhen New Industries Biomedical Engineering

Began his career with the company when it was a trading firm.

2020

Shenzhen New Industries IPO

The company went public on the Shenzhen Stock Exchange, raising significant capital for R&D and manufacturing.

Philanthropy & Social Impact

Education, Health and Environment

Rao Family Foundation

$1.3M (2024)

Focused on providing Education, Health, and Environment support in the Dallas-Fort Worth Metroplex.